| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/03/2004 | EP1392336A1 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof |
| 03/03/2004 | EP1392253A2 Gelatin substitute |
| 03/03/2004 | EP1392106A1 Tyra genes and uses thereof |
| 03/03/2004 | EP1392104A2 Sugar and lipid metabolism regulators in plants ii |
| 03/03/2004 | EP1196440B1 Therapeutic peptides derived from subsequences of bpi |
| 03/03/2004 | EP1149167B1 Viral vaccine |
| 03/03/2004 | EP1114161B1 Immunoglobulin binding protein |
| 03/03/2004 | EP1062224A4 Modified factor viii |
| 03/03/2004 | EP1037655B1 use of novel ligands of the neuropeptide receptor hfgan72 and antagonists thereof in therapy |
| 03/03/2004 | EP1025253B1 Positive-negative selection for homologous recombination |
| 03/03/2004 | EP1019025B1 Peptide/lipid complex formation by co-lyophilization |
| 03/03/2004 | EP1011716B9 Neuromedin b receptor antagonists |
| 03/03/2004 | EP0983290B1 Method for producing polymers having nucleo-bases as side-groups |
| 03/03/2004 | EP0948518B1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 03/03/2004 | EP0904355B1 Method of activating denatured protein |
| 03/03/2004 | EP0871459B1 Vector and method of use for nucleic acid delivery to non-dividing cells |
| 03/03/2004 | EP0797671B1 A process of producing extracellular proteins in bacteria |
| 03/03/2004 | EP0774119B1 Oligomer carrier molecules in which marker groups and haptens are selectively incorporated |
| 03/03/2004 | EP0719150B1 Cellular vaccine and its use for the treatment of solid tumor malignancies |
| 03/03/2004 | EP0647268B1 Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease |
| 03/03/2004 | EP0636028B1 Self-assembling polynucleotide delivery system comprising an amphiphatic cationic peptide |
| 03/03/2004 | EP0633929B1 METHOD FOR $i(IN VITRO) PROLIFERATION OF DENDRITIC CELL PRECURSORS AND THEIR USE TO PRODUCE IMMUNOGENS |
| 03/03/2004 | EP0613375B1 Pharmaceutical lysine-containing polypeptide compositions and the use thereof |
| 03/03/2004 | CN1479788A Lactic acid bacteria capable of reducing indvidual's tendency to develop allergic reactions |
| 03/03/2004 | CN1479748A Anti-abnormal prion monoclonal antibody, process for producing the same and immunoassay method with the use thereof |
| 03/03/2004 | CN1479627A Method of protein purification and recovery |
| 03/03/2004 | CN1478793A Method of extracting soluble substrate protein from pearl material |
| 03/03/2004 | CN1478792A Oyster low molecular active peptide and its preparation method and application in the preparation of anticancer medicine |
| 03/03/2004 | CN1478791A Beta tubulin of cotton fiber and its coding gene and application |
| 03/03/2004 | CN1478790A Pronucleus preparation of nipple tumour virus capsid protein and application |
| 03/03/2004 | CN1478549A Recombination protein for preventing human trachoma bedsnia infestation and its use |
| 03/03/2004 | CN1478546A Synergistic action of ossification growth peptide and granule cell colony stimulating factor in hematopoiesis |
| 03/03/2004 | CN1478544A Use of polypeptide protein kind active substance in Arca inflate Roeve and its extraction method |
| 03/03/2004 | CN1478543A Therapeutic use of bactericidal/permeability improving protein product |
| 03/03/2004 | CN1140629C Genes of purine biosynthesis from ashbya gossypli and use thereof in microbial riboflavin synothesis |
| 03/03/2004 | CN1140627C Recombinant virus of human vascular endothelial growth inhibitor |
| 03/03/2004 | CN1140536C Minotopes and anti-mimotopes of human platelet glycoprotein Ib/Ix |
| 03/03/2004 | CN1140529C Aluminoxane sythesis empolying reduced amount of trialkylaluminium compound |
| 03/03/2004 | CN1140294C Use of VIP, analogues and fragments thereof for the treatment of neurodegemeratiue diseases |
| 03/02/2004 | US6699973 Gastro-intestinal tract (git); used to determine fate of drugs attached to git-targeting agents |
| 03/02/2004 | US6699971 For the detection of the presence of epstein barr virus |
| 03/02/2004 | US6699970 Mutacin I biosynthesis genes and proteins |
| 03/02/2004 | US6699968 Fusion protein that includes a functional heparin sulfate attachment sequece placed into other proteins that normally do not have haparan sulfate glycosaminoglycan chains; links functional domains to biological effector molecules |
| 03/02/2004 | US6699967 Used to treat, prevent, or delay a tissue proliferation-associated disorder |
| 03/02/2004 | US6699966 Proteins within the type E botulinum neurotoxin complex |
| 03/02/2004 | US6699965 Used for as a drug screening target; protein from rat and human brains |
| 03/02/2004 | US6699905 Comprising administering to the subject an effective anti-inflammatory amount of a pharmaceutical composition comprising a lipoxin a4 compound and a pharmaceutically acceptable carrier |
| 03/02/2004 | US6699843 Method for treatment of tumors using nucleic acid ligands to PDGF |
| 03/02/2004 | US6699839 Treating bacterial infection by administering composition including isolated mutacin b-ny266 polypeptide, having specified amino acid sequence, and specified residues are capable of forming lanthionine or b-methyllanthionine bridges |
| 03/02/2004 | US6699837 Treatment of neurons with HGF |
| 03/02/2004 | US6699834 Administering therapeutically effective amount of isolated protein or peptide comprising at least one segment selected from 5 to 50 amino acid segment of sequence of human chorionic gonadotropin beta-chain |
| 03/02/2004 | US6699715 Has variable heavy chain and a variable light chain which recognize and bind a cd28 receptor, fc region, and a portion of the transmembrane region of a b7 receptor, fusion protein; immunotherapy; single chain fv fragments (sfv) |
| 03/02/2004 | US6699714 Used to evaluate efficacy of drugs for prostate cancer treatment; nucleic acid sequences used for androgenic or anti-androgenic activity |
| 03/02/2004 | US6699703 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 03/02/2004 | US6699692 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
| 03/02/2004 | US6699690 Linked and controlling the expression of a heterologous enzyme, for example varicella zoster virus thymidine kinase or non-mammaliam cytosine deaminase |
| 03/02/2004 | US6699689 Mass production method of antimicrobial peptide and DNA construct and expression system thereof |
| 03/02/2004 | US6699688 Human platelet F11 receptor |
| 03/02/2004 | US6699687 Circularly permuted fluorescent protein indicators |
| 03/02/2004 | US6699686 Modified nuclear glucocorticoid receptor, fusion protein, and DNA fragments coding for said receptor and said fusion protein |
| 03/02/2004 | US6699678 Chlamydia trachomatis specific peptides and their use in diagnostic assays |
| 03/02/2004 | US6699677 Identifying a ligand-orphan receptor interaction by use of immobilized tethered ligand fusion proteins having a ligand domain, a stalk domain, and optionally an immobilization domain; drug screening, diagnosis |
| 03/02/2004 | US6699675 Marker for inflammatory conditions |
| 03/02/2004 | US6699674 Expression and refolding of truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi and its use in antibody based detection assays and vaccines |
| 03/02/2004 | US6699671 Polypeptide sequence encoding beta secretase enzyme, termed aspartyl protease 2 (as p2) involved in processing amyloid precursor protein (app) into amyloid beta; drug screening for the enzyme inhibitor |
| 03/02/2004 | US6699666 Method for the diagnosis of cell proliferative disease |
| 03/02/2004 | US6699664 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 03/02/2004 | US6699663 Molecular sequence of swine retrovirus |
| 03/02/2004 | US6699660 Isolated nucleic acid identical to one expressed in response to seizure or ischemia |
| 03/02/2004 | US6699656 Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin |
| 03/02/2004 | US6699482 Leptospira rare outer membrane proteins |
| 03/02/2004 | US6699481 Peptides for inhibition of herpes simplex virus entry |
| 03/02/2004 | US6699480 Vaccine compositions |
| 03/02/2004 | US6699478 Does not induce enhanced disease (e.g., atypical pulmonary inflammation) |
| 03/02/2004 | US6699477 EBV CTL epitopes |
| 03/02/2004 | US6699476 Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules |
| 03/02/2004 | US6699475 Recombinant pox virus for immunization against tumor-associated antigens |
| 03/02/2004 | US6699468 Defective expression of the gamma 34.5 gene and the ribonucleotide reductase gene |
| 03/02/2004 | US6699466 IL-16 antagonist peptides and DNA encoding the peptides |
| 03/02/2004 | US6699465 Chemical structure for use in the prevention and treatment of viral infections |
| 03/02/2004 | US6699386 Can be used to remove endotoxin highly selectively from solutions such as endotoxin-containing pharmaceutical preparations or blood containing proteins at high concentration |
| 03/02/2004 | CA2229405C Methods for enhancing the production of interferon in cell culture |
| 03/02/2004 | CA2196906C Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| 03/02/2004 | CA2149441C Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 03/02/2004 | CA2069960C Bispecific heteroantibodies with dual effector functions |
| 02/26/2004 | WO2004016812A1 Avian sex determination method |
| 02/26/2004 | WO2004016811A2 Methods and kit for genes shuffling using tagged primers |
| 02/26/2004 | WO2004016810A2 Use of an mrp4 binding substances for the diagnosis and treatment of cancer |
| 02/26/2004 | WO2004016799A2 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER |
| 02/26/2004 | WO2004016795A1 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 02/26/2004 | WO2004016794A1 Replicons of pestiviruses that do not express c and or e1 protein and infectious viral particles containing same, that can be used in vaccines |
| 02/26/2004 | WO2004016793A2 Method of plastid transformation in asteraceae, vector for use therein and plants thus obtained |
| 02/26/2004 | WO2004016792A1 Novel expression vector suitable for expression of recombinant protein at low temperature |
| 02/26/2004 | WO2004016788A1 Splicing-variant of the human p53 protein and use thereof in the production of pharmaceutical preparations for treating tumoural diseases |
| 02/26/2004 | WO2004016785A1 Method of examining atopic dermatitis |
| 02/26/2004 | WO2004016784A1 Protease inhibitor |
| 02/26/2004 | WO2004016783A1 Method of examining atopic dermatitis |
| 02/26/2004 | WO2004016781A1 Human-origin proteins forming domain and use thereof |
| 02/26/2004 | WO2004016776A1 Use of cdx2 +/- heterozygous animals for the screening of carcinogenic or anti-cancerous factors |
| 02/26/2004 | WO2004016775A2 Plants having modified growth and a method for making the same |